Magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) allow the
chemical analysis of physiological processes in vivo and provide powerful tools in the life …

Magnetic resonance spectroscopy (MRS) is a non-invasive and non-ionizing technique,
enabling in vivo investigation of cardiac metabolism in normal and diseased hearts. In vivo …

Cardiovascular diseases (CVD) are important consequences of adverse perinatal conditions
such as fetal hypoxia and maternal malnutrition. Cardiac magnetic resonance imaging …

The liver plays a central role in metabolic homeostasis, as exemplified by a variety of clinical
disorders with hepatic and systemic metabolic disarrays. Of particular interest are the …

Background Single-voxel proton cardiovascular magnetic resonance spectroscopy (1 H-
CMRS) benefits from 3 T to detect metabolic abnormalities with the quantification of …

Purpose Respiratory gating in cardiac water‐suppressed (WS) proton spectroscopy leads to
long and unpredictable scan times. Metabolite cycling allows to perform frequency and …

Background Cardiac involvement of amyloidosis leads to left-ventricular (LV) wall thickening
with progressive heart failure requiring rehospitalization. Cardiovascular magnetic …

Introduction Single‐voxel 1H MRS in body applications often suffers from respiratory and
other motion induced phase and frequency shifts, which lead to incoherent averaging and …

Cardiac proton spectroscopy (1H‐MRS) is widely used to quantify lipids. Other metabolites
(eg creatine and choline) are clinically relevant but more challenging to quantify because of …

Purpose Spectroscopic imaging could provide insights into regional cardiac triglyceride
variations, but is hampered by relatively long scan times. It is proposed to synergistically …